Voyager Therapeutics, Inc. (NASDAQ:VYGR) is held by 122 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 5,618,365 | 11,094 | 0.20% | $22,080,174.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 4,002,847 | 3,332,544 | 497.17% | $15,731,189.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 4,000,000 | -200,000 | -4.76% | $15,720,000.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,266,484 | 16,418 | 0.51% | $12,837,282.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,880,760 | -411,943 | -17.97% | $7,391,387.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 1,475,000 | 0 | 0.00% | $5,796,750.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 1,196,904 | 1,196,904 | 0.00% | $4,703,833.00 |
| Erste Asset Management GmbH | 31 Dec, 2025 | 1,195,141 | 78,348 | 7.02% | $4,717,683.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,135,188 | -13,424 | -1.17% | $4,462,072.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 1,084,499 | -198,657 | -15.48% | $4,262,123.00 |
| State Street Corp | 31 Dec, 2025 | 936,266 | 10,908 | 1.18% | $3,679,525.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 606,266 | 308,693 | 103.74% | $2,382,626.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 556,646 | 158,420 | 39.78% | $2,187,618.00 |
| Morgan Stanley | 31 Dec, 2025 | 544,114 | -55,574 | -9.27% | $2,138,368.00 |
| Northern Trust Corp | 31 Dec, 2025 | 368,546 | -26,205 | -6.64% | $1,448,386.00 |
| SPHERA FUNDS MANAGEMENT LTD. | 31 Dec, 2025 | 339,761 | 140,000 | 70.08% | $1,335,261.00 |
| FIDUCIARY TRUST CO | 31 Dec, 2025 | 334,397 | 0 | 0.00% | $1,314,180.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 326,230 | -108,592 | -24.97% | $1,282,085.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 296,450 | 34,000 | 12.95% | $1,165,049.00 |
| UBS Group AG | 31 Dec, 2025 | 268,793 | -204,307 | -43.18% | $1,056,357.00 |